Terenz Company
Terenz simplifies the diagnosis of Neurodegenerative Diseases by leveraging Artifiical Intelligence .
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Busan, Pusan-jikhalsi, South Korea
Founded Date:
2019-03-06
Last Funding Date:
2021-03-01
Employee Number:
1-10
Estimated Revenue:
$1M to $10M
Industry:
Neurodegeneration and Aging